<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial</dc:title>
  <dc:creator>/Sagaon Teyssier, Luis</dc:creator>
  <dc:creator>Suzan-Monti, M.</dc:creator>
  <dc:creator>Demoulin, B.</dc:creator>
  <dc:creator>Capitant, C.</dc:creator>
  <dc:creator>et al.</dc:creator>
  <dc:subject>SIDA</dc:subject>
  <dc:subject>PREVENTION SANITAIRE</dc:subject>
  <dc:subject>COMPORTEMENT SEXUEL</dc:subject>
  <dc:subject>TRANSMISSION</dc:subject>
  <dc:subject>ENQUETE</dc:subject>
  <dc:subject>HOMOSEXUALITE</dc:subject>
  <dc:subject>PRESERVATIF</dc:subject>
  <dc:description>The double-blind phase of the randomized ANRS IPERGAY trial, evaluating sexual activity-based oral HIV pre-exposure prophylaxis (PrEP), was conducted among high-risk men who have sex with men (MSM). Results showed an 86% (95% CI: 40-98) relative reduction in HIV incidence among participants with tenofovir disoproxil fumarate-emtricitabine vs. placebo. The present pooled analysis aimed to analyze (i) participants' adherence to the prescribed treatment and/or condom use during sexual intercourse and (ii) sexual behavior during the double-blind phase of the study. Four hundred MSM were enrolled in the trial. Every 2 months they completed online questionnaires collecting sexual behavior and PrEP adherence data regarding their most recent sexual intercourse. A total of 2232 questionnaires (M0-M24) were analyzed. Changes over time were evaluated using a mixed model accounting for multiple measures. Irrespective of sexual partner and practice type, on average, 42.6% (min: 32.1-max: 45.8%) reported PrEP use only during their most recent episode of sexual intercourse; 29% (22.9-35.6%) reported both PrEP and condom use; 11.7% (7.2-18.9%) reported condom-use only, and 16.7% (10.8-29.6%) reported no PrEP or condom use with no significant change during the study. Scheduled (i.e., correct) PrEP use was reported on average by 59.0% (47.2-68.5%) of those reporting PrEP use during their most recent sexual intercourse. Overall, 70.3% (65.3-79.4%) and 69.3% (58.3-75.4%) of participants reported, respectively, condomless anal and condomless receptive anal intercourse during their most recent sexual encounter without significant change during follow-up. Overall, on average 83.3% (min: 70.4-max: 89.2%) of participants protected themselves by PrEP intake or condom use or both during the trial, and no increase in at-risk sexual practices was observed. None of these indicators showed significant trend during the follow-up, although we found a tendency toward decrease (p = .19) of the median number of sexual partners strengthening the absence of behavioral disinhibition. On-demand PrEP within a comprehensive HIV prevention package could improve prevention in MSM.</dc:description>
  <dc:date>2016</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010074660</dc:identifier>
  <dc:identifier>fdi:010074660</dc:identifier>
  <dc:identifier>Sagaon Teyssier Luis, Suzan-Monti M., Demoulin B., Capitant C., et al.. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. 2016, 28 (S1 No Sp&#xE9;cial AIDS Impact),  48-55 AIDS Impact Conference Supplement, Amsterdam (NLD), 2015</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>FRANCE</dc:coverage>
</oai_dc:dc>
